Trial intelligence / Profile preview

Ezetimibe Added to Statin Therapy in Primary Hypercholesterolemia

NCT03882905Phase 3Completed

Sponsor
Organon & Co.
Start
Jan 2001
Primary completion
Jul 2001
Modality
Small Molecules
01

Overview

A Phase 3 trial of ezetimibe in hypercholesterolemia, sponsored by Organon & Co.. Started Jan 2001; status: completed.

02

Drugs

ezetimibe
03

Conditions

hypercholesterolemia

Beyond the preview

Go deeper on NCT03882905.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03882905.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call